Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NovoCure LtdNVCR · Entity 4494 | Chief Operating Officer | July 21, 2020 | July 23, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NovoCure Ltd
Report date July 21, 2020 · Filed July 23, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 220,867 |
Ending reported balance
After 2020-07-22 transaction · row 15
15 source rows · reconciled sequenceRow 1 · 2020-07-21 · Exercise / conversion · Acquired 300 · Balance 221,167 Row 2 · 2020-07-21 · Sale · Disposed 300 · Balance 220,867 F1: On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 300 shares in multiple trades at prices ranging from $65.00 to $65.11. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2020-07-21 · Exercise / conversion · Acquired 3,021 · Balance 223,888 Row 4 · 2020-07-21 · Sale · Disposed 3,021 · Balance 220,867 F2: On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 3,021 shares in multiple trades at prices ranging from $65.00 to $65.31. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Row 5 · 2020-07-22 · Exercise / conversion · Acquired 8,426 · Balance 229,293 Row 6 · 2020-07-22 · Sale · Disposed 400 · Balance 228,893 F3: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 400 shares in multiple trades at prices ranging from $65.16 to $65.82. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Row 7 · 2020-07-22 · Sale · Disposed 4,228 · Balance 224,665 F4: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 4,228 shares in multiple trades at prices ranging from $66.21 to $67.19. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Row 8 · 2020-07-22 · Sale · Disposed 3,798 · Balance 220,867 F5: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 3,798 shares in multiple trades at prices ranging from $67.21 to $67.80. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Row 9 · 2020-07-22 · Exercise / conversion · Acquired 3,774 · Balance 224,641 Row 10 · 2020-07-22 · Sale · Disposed 1,151 · Balance 223,490 F6: On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 1,151 shares in multiple trades at prices ranging from $65.76 to $66.75. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Row 11 · 2020-07-22 · Sale · Disposed 2,623 · Balance 220,867 F7: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 2,623 shares in multiple trades at prices ranging from $66.79 to $67.64. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Row 12 · 2020-07-22 · Exercise / conversion · Acquired 30,772 · Balance 251,639 Row 13 · 2020-07-22 · Sale · Disposed 1,380 · Balance 250,259 F8: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 1,380 shares in multiple trades at prices ranging from $65.00 to $65.92. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Row 14 · 2020-07-22 · Sale · Disposed 12,217 · Balance 238,042 F9: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 12,217 shares in multiple trades at prices ranging from $66.03 to $67.02. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Row 15 · 2020-07-22 · Sale · Disposed 17,175 · Balance 220,867 F10: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 17,175 shares in multiple trades at prices ranging from $67.04 to $67.94. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. |
| Options to Buy Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $11.46 · Expires 2026-02-24 | Direct | 8,426 |
Reported balance
After 2020-07-21 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2020-07-21 · Exercise / conversion · Disposed 300 · Balance 8,426 F11: Fully vested as of the date hereof. |
| Options to Buy Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $21.15 · Expires 2028-02-26 | Direct | 98,358 |
Reported balance
After 2020-07-21 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2020-07-21 · Exercise / conversion · Disposed 3,021 · Balance 98,358 F12: Fully-vested as of the date hereof except for options to purchase 67,586 ordinary shares, which will vest in equal installments on each of 2/26/21 and 2/26/22, subject to the reporting person's continued employment through such dates. |
| Options to Buy Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $11.46 · Expires 2026-02-24 | Direct | 0 |
Reported balance
After 2020-07-22 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2020-07-22 · Exercise / conversion · Disposed 8,426 · Balance 0 F11: Fully vested as of the date hereof. |
| Options to Buy Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $11.46 · Expires 2026-02-24 | Direct | 0 |
Reported balance
After 2020-07-22 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2020-07-22 · Exercise / conversion · Disposed 3,774 · Balance 0 F11: Fully vested as of the date hereof. |
| Options to Buy Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $21.15 · Expires 2028-02-26 | Direct | 67,586 |
Reported balance
After 2020-07-22 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2020-07-22 · Exercise / conversion · Disposed 30,772 · Balance 67,586 F13: Options to purchase 67,586 ordinary shares will vest and become exercisable in equal installments on each of 2/26/21 and 2/26/22, subject to the reporting person's continued employment through such dates. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 300 shares in multiple trades at prices ranging from $65.00 to $65.11. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F2: On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 3,021 shares in multiple trades at prices ranging from $65.00 to $65.31. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F3: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 400 shares in multiple trades at prices ranging from $65.16 to $65.82. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F4: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 4,228 shares in multiple trades at prices ranging from $66.21 to $67.19. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F5: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 3,798 shares in multiple trades at prices ranging from $67.21 to $67.80. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F6: On July 21, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 1,151 shares in multiple trades at prices ranging from $65.76 to $66.75. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F7: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 2,623 shares in multiple trades at prices ranging from $66.79 to $67.64. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F8: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 1,380 shares in multiple trades at prices ranging from $65.00 to $65.92. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F9: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 12,217 shares in multiple trades at prices ranging from $66.03 to $67.02. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F10: On July 22, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 17,175 shares in multiple trades at prices ranging from $67.04 to $67.94. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
F11: Fully vested as of the date hereof.
F12: Fully-vested as of the date hereof except for options to purchase 67,586 ordinary shares, which will vest in equal installments on each of 2/26/21 and 2/26/22, subject to the reporting person's continued employment through such dates.
F13: Options to purchase 67,586 ordinary shares will vest and become exercisable in equal installments on each of 2/26/21 and 2/26/22, subject to the reporting person's continued employment through such dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2017 Filed Jan 6, 2017 16:07 UTC | NovoCure Ltd NVCR · Entity 4494 | GrantOrdinary Shares | 1,108 | $6.67 | $7,393.68 |
DisclosureSEC source: 0000899243-17-000677 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,692 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of August 1, 2016 through December 31, 2016. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 30, 2016. Read SEC document |
| December 22, 2016 Filed Dec 22, 2016 16:59 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 7,500 | $8.09 | $60,695.25 |
DisclosureSEC source: 0000899243-16-036261 · doc4.xml · nonDerivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,584 F2 · price: On December 22, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 7,500 shares in multiple trades at prices ranging from $8.00 to $8.175. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 21, 2016 Filed Dec 22, 2016 16:59 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 20,000 | $8.33 | $166,608.00 |
DisclosureSEC source: 0000899243-16-036261 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,084 F1 · price: On December 21, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.075 to $8.65. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 20, 2016 Filed Dec 21, 2016 16:50 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 20,000 | $8.62 | $172,476.00 |
DisclosureSEC source: 0000899243-16-036180 · doc4.xml · nonDerivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,084 F2 · price: On December 20, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.525 to $8.80. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 19, 2016 Filed Dec 21, 2016 16:50 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 20,000 | $8.76 | $175,178.00 |
DisclosureSEC source: 0000899243-16-036180 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,084 F1 · price: On December 19, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.55 to $9.05. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 20,000 | $8.71 | $174,270.00 |
DisclosureSEC source: 0000899243-16-035928 · doc4.xml · nonDerivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,084 F2 · price: On December 16, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.425 to $9.15. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 20,000 | $9.14 | $182,858.00 |
DisclosureSEC source: 0000899243-16-035928 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,084 F1 · price: On December 15, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $9.00 to $9.375. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 20,000 | $8.96 | $179,294.00 |
DisclosureSEC source: 0000899243-16-035594 · doc4.xml · nonDerivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,084 F2 · price: On December 14, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.65 to $9.15. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 20,000 | $8.98 | $179,688.00 |
DisclosureSEC source: 0000899243-16-035594 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,084 F1 · price: On December 13, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,000 shares in multiple trades at prices ranging from $8.65 to $9.40. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 16:06 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 10,000 | $9.04 | $90,442.00 |
DisclosureSEC source: 0000899243-16-035397 · doc4.xml · nonDerivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,084 F2 · price: On December 12, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 10,000 shares in multiple trades at prices ranging from $8.80 to $9.40. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 16:06 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 5,000 | $8.93 | $44,668.00 |
DisclosureSEC source: 0000899243-16-035397 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,084 F1 · price: On December 9, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 5,000 shares in multiple trades at prices ranging from $8.70 to $9.20. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 08, 2016 Filed Dec 9, 2016 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 5,000 | $8.37 | $41,831.50 |
DisclosureSEC source: 0000899243-16-035218 · doc4.xml · nonDerivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,084 F2 · price: On December 8, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 5,000 shares in multiple trades at prices ranging from $7.975 to $8.75. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 5,000 | $8.24 | $41,175.00 |
DisclosureSEC source: 0000899243-16-035218 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,084 F1 · price: On December 7, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 5,000 shares in multiple trades at prices ranging from $7.90 to $8.40. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 06, 2016 Filed Dec 7, 2016 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 5,000 | $8.22 | $41,110.00 |
DisclosureSEC source: 0000899243-16-035034 · doc4.xml · nonDerivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,084 F2 · price: On December 6, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 5,000 shares in multiple trades at prices ranging from 7.95 to 8.40. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 16:05 UTC | NovoCure Ltd NVCR · Entity 4494 | SaleOrdinary Shares | 5,000 | $8.25 | $41,245.00 |
DisclosureSEC source: 0000899243-16-035034 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,084 F1 · price: On December 5, 2016, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 5,000 shares in multiple trades at prices ranging from 8.05 to 8.35. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.